DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aarti Pharmalabs Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 52 min ago·9 Oct 2026, 7:23 am

Aarti Pharmalabs

Aarti Pharmalabs Limited has informed the stock exchanges that it has obtained a Certificate of Compliance under SEBI’s Depositories and Participants Regulations, 2018. This document confirms that the company has successfully completed the necessary formalities for its listed securities to be held in electronic form.

This regulatory milestone is a routine administrative requirement for listed companies. It ensures that the company's shares are eligible for dematerialization and electronic trading on the stock market. For investors, this is a standard procedural update that maintains the integrity of the company's listing status.

Investors should view this as a standard corporate governance update rather than a market-moving event. The focus should remain on the company's core business performance and operational metrics. There are no immediate implications for trading or valuations based on this disclosure.